BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26825879)

  • 1. GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report.
    Patel SP; Kim DW; Lacey CL; Hwu P
    Medicine (Baltimore); 2016 Jan; 95(4):e2336. PubMed ID: 26825879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population.
    Yilmaz I; Gamsizkan M; Kucukodaci Z; Berber U; Demirel D; Haholu A; Narli G
    Indian J Pathol Microbiol; 2015; 58(3):279-84. PubMed ID: 26275246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.
    Chang LW; Kazlouskaya V; Kazi R; Davar D; Ferris RL; Ho J; Karunamurthy A; Jedrych JJ; Bunimovich YL
    Am J Dermatopathol; 2020 Nov; 42(11):854-857. PubMed ID: 32310862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
    Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
    J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNAQ mutation in a patient with metastatic mucosal melanoma.
    Kim CY; Kim DW; Kim K; Curry J; Torres-Cabala C; Patel S
    BMC Cancer; 2014 Jul; 14():516. PubMed ID: 25030020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
    Xu X; Wei WB; Li B; Gao F; Zhang Z; Jonas JB
    PLoS One; 2014; 9(10):e109699. PubMed ID: 25280020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
    Moore AR; Ran L; Guan Y; Sher JJ; Hitchman TD; Zhang JQ; Hwang C; Walzak EG; Shoushtari AN; Monette S; Murali R; Wiesner T; Griewank KG; Chi P; Chen Y
    Cell Rep; 2018 Feb; 22(9):2455-2468. PubMed ID: 29490280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant GNA11 and SF3B1 mutations in two cases of melanoma associated with blue naevus.
    Danset M; Milley S; Harou O; Vasseur D; Amini-Adle M; Thomas L; Dalle S; Balme B; Lopez J
    Clin Exp Dermatol; 2020 Jan; 45(1):123-126. PubMed ID: 31338849
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas.
    Rushton JG; Korb M; Kummer S; Reichart U; Fuchs-Baumgartinger A; Tichy A; Nell B
    Vet J; 2019 Jul; 249():33-40. PubMed ID: 31239162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
    Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
    Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
    Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
    Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.